ATX Amplia Therapeutics Limited
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Around Friday 27 August 2027
Estimated 52 weeks after the last AGM. This will update when the company announces its date or lodges its notice of meeting.
Last AGM voting results
Results of the AGM held Friday 28 August 2026.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 1 | Remuneration Report | 99.73% | 0.27% | carried |
| 2 | Re-elect Dr Robert Peach as a Director of the Company | 99.98% | 0.02% | carried |
| 3 | Elect Mr Brett Carter as a Director of the Company | 99.92% | 0.08% | carried |
| 4 | Facility | 77.63% | 22.37% | carried |
| 5 | Increase in Non-Executive Directors’ Fee Pool | 99.34% | 0.66% | carried |
| 6 | Proposed Issue of Zero Exercise Price Options to Dr Christopher Burns (Managing Director a | 99.44% | 0.56% | carried |
| 7 | Executive Officer) Proposed Issue of Zero Exercise Price Options to Ms Jane Bell (Non Exec | 99.12% | 0.88% | carried |
| 8 | Proposed Issue of Zero Exercise Price Options to Dr Robert Peach (Non Executive Director) | 99.08% | 0.92% | carried |
| 9 | Proposed Issue of Zero Exercise Price Options to Dr Warwick Tong (Non Executive Director) | 99.12% | 0.88% | carried |
| 10 | Proposed Issue of Zero Exercise Price Options to Mr Brett Carter (Non Executive Director) | 99.13% | 0.87% | carried |
Protest vote: 20% or more against, or not carried.
The AGM before that (Wednesday 27 August 2025): 0.14% against the remuneration report. Results ↗